Target Name: LOC101926953
NCBI ID: G101926953
Review Report on LOC101926953 Target / Biomarker Content of Review Report on LOC101926953 Target / Biomarker
LOC101926953
Other Name(s): uncharacterized LOC101926953 | Uncharacterized LOC105370115, transcript variant X4 | LOC101926953 variant X4

LOC101926953: A Potential Drug Target or Biomarker

LOC101926953 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its unique structure and subcellular localization suggest that it may play a critical role in the function of these tissues. While more research is needed to fully understand its functions, LOC101926953 has potential as a drug target or biomarker.

The protein LOC101926953 is a member of the gene family known as the homeobox gene family (Hox), which is characterized by the presence of a putative nuclear hormone receptor (NHR) domain in the amino-terminal region. Hox genes are involved in the regulation of cellular processes that are critical for development, growth, and survival, and are implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

LOC101926953 is a 21-kDa protein that is expressed in the brain, heart, and kidneys, and has been shown to localize to specific cellular structures in these tissues. It is predominantly expressed in the brain, where it is present in the cell body, as well as in the endoplasmic reticulum (ER) and in the nuclear envelope (NE). These localizations suggest that LOC101926953 may be involved in the regulation of important cellular processes that are specific to these tissues.

In addition to its localization to specific tissues, LOC101926953 is also characterized by a unique structure that may be involved in its function. The protein has a characteristic N-terminal region that is rich in conserved putative NHR domains, as well as a C-terminal region that is involved in its stability and localization to the ER and NE. The NHR domains are known to be involved in the regulation of nuclear factor kappa B (NF-kappa-B), a transcription factor that plays a critical role in the regulation of inflammation, stress, and cellular processes that are important for survival.

The C-terminal region of LOC101926953 is rich in conserved amino acids that are involved in its stability and localization to the ER and NE. This region includes a stretch of amino acids that is known as the \"z-disc,\" which is involved in the formation of stress-proteins that are targeted for degradation by the endoplasmic reticulum. The z-disc is also involved in the regulation of the stability of LOC101926953, as alterations in its localization to the ER and NE have been shown to affect its stability and to influence its function.

While more research is needed to fully understand the functions of LOC101926953, its unique structure and subcellular localization suggest that it may play a critical role in the regulation of important cellular processes that are specific to the brain, heart, and kidneys. As such, LOC101926953 has potential as a drug target or biomarker for a wide range of diseases, including those related to neurodegenerative diseases, cancer, and developmental disorders. Further studies are needed to determine the full extent of LOC101926953's involvement in these processes and to develop effective strategies for targeting it as a potential therapeutic agent.

Protein Name: Uncharacterized LOC101926953

The "LOC101926953 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101926953 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026 | LOC101927040 | LOC101927053 | LOC101927060 | LOC101927066 | LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164 | LOC101927166 | LOC101927169 | LOC101927179 | LOC101927188 | LOC101927199 | LOC101927216 | LOC101927243 | LOC101927245 | LOC101927253 | LOC101927263 | LOC101927269 | LOC101927314 | LOC101927369 | LOC101927394 | LOC101927421 | LOC101927476 | LOC101927483 | LOC101927495 | LOC101927518 | LOC101927531 | LOC101927548 | LOC101927550 | LOC101927571 | LOC101927588 | LOC101927598 | LOC101927605 | LOC101927609 | LOC101927627 | LOC101927636 | LOC101927668 | LOC101927712 | LOC101927727 | LOC101927741 | LOC101927745 | LOC101927770 | LOC101927787 | LOC101927825 | LOC101927827 | LOC101927834 | LOC101927840 | LOC101927853 | LOC101927855 | LOC101927857 | LOC101927863 | LOC101927896 | LOC101927897 | LOC101927910 | LOC101927932 | LOC101927942 | LOC101927947 | LOC101927960 | LOC101927967 | LOC101927971 | LOC101927995 | LOC101927998 | LOC101928004 | LOC101928007 | LOC101928008 | LOC101928012 | LOC101928014 | LOC101928047 | LOC101928053 | LOC101928080 | LOC101928093 | LOC101928120 | LOC101928135 | LOC101928143 | LOC101928152 | LOC101928163 | LOC101928180 | LOC101928195 | LOC101928201 | LOC101928219 | LOC101928230 | LOC101928251 | LOC101928268 | LOC101928269 | LOC101928272 | LOC101928273 | LOC101928274 | LOC101928281 | LOC101928331 | LOC101928334 | LOC101928338 | LOC101928344 | LOC101928347